Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2004. Start Trial.
Date Value
June 30, 2026 59.45%
March 31, 2026 60.27%
December 31, 2025 60.78%
September 30, 2025 59.96%
June 30, 2025 58.86%
March 31, 2025 60.62%
December 31, 2024 57.95%
September 30, 2024 58.90%
June 30, 2024 60.16%
March 31, 2024 59.47%
December 31, 2023 54.94%
September 30, 2023 56.79%
June 30, 2023 56.23%
March 31, 2023 55.85%
December 31, 2022 58.48%
September 30, 2022 55.37%
June 30, 2022 55.76%
March 31, 2022 57.66%
December 31, 2021 58.68%
September 30, 2021 56.24%
June 30, 2021 59.71%
March 31, 2021 59.74%
December 31, 2020 62.98%
September 30, 2020 57.29%
June 30, 2020 62.51%
Date Value
March 31, 2020 59.25%
December 31, 2019 58.29%
September 30, 2019 53.30%
June 30, 2019 54.33%
March 31, 2019 58.22%
December 31, 2018 57.77%
September 30, 2018 56.65%
June 30, 2018 57.06%
March 31, 2018 57.91%
December 31, 2017 55.52%
September 30, 2017 57.07%
June 30, 2017 54.91%
March 31, 2017 53.34%
December 31, 2016 51.17%
September 30, 2016 53.75%
June 30, 2016 50.48%
March 31, 2016 48.12%
December 31, 2015 48.27%
September 30, 2015 48.69%
June 30, 2015 48.13%
March 31, 2015 47.83%
December 31, 2014 46.91%
September 30, 2014 50.68%
June 30, 2014 51.64%
March 31, 2014 48.39%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Coloplast A/S 66.73%
Enovis Corp. 54.51%
Edwards Lifesciences Corp. 78.09%
Intuitive Surgical, Inc. 67.76%
Kewaunee Scientific Corp. 29.61%